Als Newswire

Als Newswire

Comprehensive Real-Time News Feed for Als.

Results 1 - 20 of 235 in Als

  1. Orangetheory Fitness Tampa Bay Burns for Augie's Quest for ALSRead the original story

    Wednesday Feb 22 | PRWeb

    ... it has partnered with Augie's Quest, a foundation dedicated to finding a cure for amyotrophic lateral sclerosis (ALS) disease, with the goal of raising $1 million in two weeks. The company's first national fundraiser, named the #IBurnForALS ...

    Comment?

  2. Timothy J. Milliman Sr.Read the original story w/Photo

    Tuesday Feb 21 | The Post-Journal, Jamestown New York

    Timothy J. Milliman Sr., 58, passed away Saturday, Feb. 18, 2017, in his home on Pancake Hill Road in Bemus Point after a yearlong battle with ALS.

    Comment?

  3. Lou Gehrig's disease: Mercury in fish, seafood could be risk factorRead the original story w/Photo

    Tuesday Feb 21 | Medical News Today

    ... Lou Gehrig's disease. Although more studies are needed, being mindful of the mercury levels in certain fish is advised. ALS predominantly targets the neurons responsible for voluntary movements, such as eating and walking. The condition steadily ...

    Comment?

  4. BrainStorm seeks early approval for stem cell treatment in CanadaRead the original story w/Photo

    Monday Feb 20 | Fox News

    Israel's BrainStorm Cell Therapeutics is seeking early approval in Canada for its adult stem cell treatment for patients with amyotrophic lateral sclerosis , a neuro-degenerative disease, even before it completes late-stage clinical trials. BrainStorm said on Tuesday that it had signed an agreement with CCRM, a Canadian not-for-profit organization that supports development of regenerative medicine, to support a market authorisation request for its ALS treatment, called NurOwn.

    Comment?

  5. Serr supports proposed Right to Try Act 0Read the original story w/Photo

    Monday Feb 20 | Northern Life

    ... Belt, issued a media release Friday throwing his support behind the Right to Try Act campaign led by the Adaptive Canuck ALS Foundation . The campaign calls for parliament to pass legislation that would grant individuals with terminal illnesses - ...

    Comment?

  6. Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) Treatment Market ...Read the original story w/Photo

    Friday Feb 17 | SBWire

    Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig's disease. There are several causes behind ALS ...

    Comment?

  7. Method developed by biomedical scientists could help in treatment of several diseasesRead the original story w/Photo

    Thursday Feb 16 | PhysOrg Weblog

    ... conversion into an aberrant protein, which could lead to disease. In some diseases, like amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease), excessive junk RNA is produced, possibly contributing to the disease. In such instances, ...

    Comment?

  8. Method developed by biomedical scientists could help in treatment of several diseasesRead the original story w/Photo

    Wednesday Feb 15 | EurekAlert!

    ... conversion into an aberrant protein, which could lead to disease. In some diseases, like amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease), excessive junk RNA is produced, possibly contributing to the disease. In such instances, ...

    Comment?

  9. Swing dancing coming to The Cooperage,Read the original story w/Photo

    Tuesday Feb 14 | The Pike County Courier

    Bruce Dedrick is a musician/singer/composer/arranger with many credits including appearances on the Tonight Show, the Merv Griffin and Mike Douglas Shows, as well as several albums/CDs as a member of the Free Design, a finely tuned vocal group who, after a hiatus of 20 years, recently released Cosmic Peekaboo, and in conjunction with The Little Big Band Group, recently performed several concerts for the benefit of the ALS Foundation. He has also had several compositions published and recorded over the years.

    Comment?

  10. Voyager Therapeutics Announces Lead Clinical Candidate Selection for...Read the original story

    Monday Feb 13 | Information Technology

    Voyager Therapeutics, Inc. , a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system , today announced the selection of VY-SOD101, a clinical candidate for the treatment of ALS due to mutations in the superoxide dismutase 1 gene . Multiple studies have demonstrated that mutant SOD1 is toxic to motor neurons, and leads to their progressive loss.

    Comment?

  11. Sullivan High senior honored for volunteer workRead the original story w/Photo

    Wednesday Feb 8 | Tribune-Star

    ... will receive an engraved bronze medallion. She organized "Run For Those Who Can't," a 5K run that raised $2,800 for the ALS Foundation and a scholarship named for her late uncle, who was diagnosed with ALS her freshman year. An active community ...

    Comment?

  12. GeNeuro Signs CRADA Agreement With NIH To Develop Novel Antibody Treatment For ALSRead the original story

    Tuesday Feb 7 | BioSpace

    The research will evaluate the ability of these antibodies to neutralise a potential causal factor of ALS, the envelope protein of HERV-K . Under the terms of the agreement, GeNeuro will provide antibodies designed to block the activity of HERV-K envelope protein.

    Comment?

  13. All out effort for friendRead the original story w/Photo

    Wednesday Feb 8 | Western Wheel

    Approximately that many people attended the Chad Kendrick fundraiser Saturday at the Turner Valley Royal Canadian Legion so the Black Diamond business owner can receive stem cell therapy to treat ALS. 'We are all in this together,' said David Campbell, a close friend of Chad Kendrick.

    Comment?

  14. MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for...Read the original story

    Tuesday Feb 7 | Customer Interaction Solutions

    MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today announced that an abstract regarding MediciNova's ongoing clinical trial of MN-166 in ALS has been accepted for presentation at the American Academy of Neurology 69th Annual Meeting to be held April 22-28, 2017 in Boston.

    Comment?

  15. Arlington Heights Hearts of Gold winners to be feted Feb. 18Read the original story w/Photo

    Friday Feb 3 | Daily Herald

    ... at the St. Edna's Food Pantry, the Outreach Ministry at St. Edna's, the Arlington Heights Veteran Association and the ALS Foundation. Ann works tirelessly for her immediate neighborhood and also for organizations within Arlington Heights. Her kind ...

    Comment?

  16. Read the original story w/Photo

    Thursday Feb 2 | Rehab Management

    New York and UK-based MeiraGTx has been awarded a research grant funded by Target ALS and ALS Finding a Cure to fund the testing of a gene therapy approach that targets the ALS-associated protein TDP-43. The grant was received to confirm and extend the initial findings on the efficacy of a therapeutic approach conducted by Dr Greg Petsko and colleagues at Weill Cornell Medicine and Brandeis University.

    Comment?

  17. French scientists win $1 million for results of treatment on mice with ALSRead the original story w/Photo

    Thursday Feb 2 | Jerusalem Post

    A genetic treatment developed by French scientists for amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, slows the advancement of the incurable neurological disease and has been called a "breakthrough" by Prize4Life, an organization founded in 2006 by a group of Harvard Business School students when one of them Israeli Avi Kremer was diagnosed with ALS. Kremer, who was 29 years old when he was diagnosed with the disease, is still active in the organization, which is dedicated to accelerating research into the disease.

    Comment?

  18. French Scientists Win Prize4Life Award for ALS Gene Therapy ApproachRead the original story w/Photo

    Wednesday Feb 1 | Rehab Management

    A team of scientists from Paris has received the $1 million Avi Kremer ALS Treatment Prize from Prize4Life for their gene therapy approach that reportedly helps extend survival and slow the progression of the disease. The scientists-Drs Martine Barkats and Maria-Grazia Biferi from the Institute of Myology U974 INSERM UMPC in Paris-developed an approach that shuts down the expression of ALS-causing gene superoxide dismutase .

    Comment?

  19. Zinc transporters ZnT3 and ZnT6 are downregulated in the spinal cords ...Read the original story

    Tuesday Jan 31 | CiteULike

    ... levels of zinc (Zn) are significantly higher in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS). Zn transporters and metallothioneins tightly control intracellular and extracellular Zn levels. This study investigated the ...

    Comment?

  20. Prize4Life Announces $1 Million ALS Treatment Prize WinnerRead the original story

    Tuesday Jan 31 | PRWeb

    Prize4Life , a nonprofit organization whose mission is to accelerate the discovery of treatments and a cure for ALS , today announced the winner of its $1M Avi Kremer ALS Treatment Prize. The winners are Drs.

    Comment?